Abstract:Peptides present an alternative modality to immunoglobulin domains or small molecules for developing therapeutics to either agonize or antagonize cellular pathways associated with diseases. However, peptides often suffer from poor chemical and physical stability, limiting their therapeutic potential. Disulfide-constrained peptides (DCP) are naturally occurring and possess numerous desirable properties, such as high stability, that qualify them as drug-like scaffolds for peptide therapeutics. DCPs contain loop regions protruding from the core of the molecule that are amenable to peptide engineering via direct evolution by use of phage display technology. In this study, we have established a robust platform for the discovery of peptide therapeutics using various DCPs as scaffolds. We created diverse libraries comprising seven different DCP scaffolds, resulting in an overall diversity of 2 x 10 11 . The effectiveness of this platform for functional hit discovery has been extensively evaluated, demonstrating a hit rate comparable to that of synthetic antibody libraries. By utilizing chemically synthesized and in vitro folded peptides derived from selections of phage displayed DCP libraries, we have successfully generated functional inhibitors targeting the HtrA1 protease. Through affinity maturation strategies, we have transformed initially weak binders against Notch2 with micromolar Kd values to high-affinity ligands in the nanomolar range. This process highlights a viable hit-to-lead progression. Overall, our platform holds significant potential to greatly enhance the discovery of peptide therapeutics.

Discovery, Structure, and Chemical Synthesis of Disulfide-Rich Peptide Toxins and Their Analogs

Research Progress in Chemical Semi-synthetic Modification of Thiopeptide Antibiotics

Opportunities and Challenges from Current Investigations into the Biosynthetic Logic of Nosiheptide-Represented Thiopeptide Antibiotics

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Sulfur-containing peptides: Synthesis and application in the discovery of potential drug candidates

DIC/Oxyma Based Efficient Synthesis and Activity Evaluation of Spider Peptide Toxin GsMTx4

Chemical Synthesis and Biological Activity of Peptides Incorporating an Ether Bridge As a Surrogate for a Disulfide Bond.

Efficient Synthesis and Oxidative Folding Studies of Centipede Toxin RhTx

Diaminodiacid Bridges to Improve Folding and Tune the Bioactivity of Disulfide-Rich Peptides

Disulfide-constrained peptide scaffolds enable a robust peptide-therapeutic discovery platform

Progress in Synthesis of Thiopeptide Antibiotics Analogues

Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides

One-pot synthesis of cysteine-rich peptide via '2,2'-dithiobispyridine' mediated sulfur exchange reaction

Diaminodiacid-based solid-phase synthesis of peptide disulfide bond mimics.

Triscysteine disulfide-directing motifs enabling design and discovery of multicyclic peptide binders

Antimicrobial Potential of Scorpion-Venom-Derived Peptides

Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists

Short-Chained Linear Scorpion Peptides: A Pool for Novel Antimicrobials

Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain

Toxins and Derivatives in Molecular Pharmaceutics: Drug Delivery and Targeted Therapy.

DIC/Oxyma‐based accelerated synthesis and oxidative folding studies of centipede toxin RhTx